Works matching IS 13866346 AND DT 2024 AND VI 54 AND IP 2
Results: 12
Rho GTPase‐activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR‐101‐3p.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 174, doi. 10.1111/hepr.13972
- By:
- Publication type:
- Article
Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 189, doi. 10.1111/hepr.13971
- By:
- Publication type:
- Article
Weighted thyroid‐stimulating hormone disturbance in prognosis of hepatitis B virus‐related acute‐on‐chronic liver failure.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 151, doi. 10.1111/hepr.13970
- By:
- Publication type:
- Article
Deciphering the dual nature of the Fibrosis‐4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 120, doi. 10.1111/hepr.13997
- By:
- Publication type:
- Article
New concept in fatty liver diseases.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 125, doi. 10.1111/hepr.14004
- By:
- Publication type:
- Article
Cost‐effectiveness of hepatitis E virus vaccination strategy.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 122, doi. 10.1111/hepr.14000
- By:
- Publication type:
- Article
Significance of the autoantibody assay in predicting the development of immune‐related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 162, doi. 10.1111/hepr.13969
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 142, doi. 10.1111/hepr.13967
- By:
- Publication type:
- Article
Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 201, doi. 10.1111/hepr.13973
- By:
- Publication type:
- Article
Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 131, doi. 10.1111/hepr.13957
- By:
- Publication type:
- Article
Integrative prediction of metabolic dysfunction‐associated fatty liver disease by endogenous fructose and related metabolism.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 213, doi. 10.1111/hepr.13956
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 117, doi. 10.1111/hepr.13914
- Publication type:
- Article